MarissaBWilckMD

Infectious Disease • Philadelphia, PA

Transplant/Immunocompromised States, Microbiology

Assistant Professor, Medicine, Perelman School of Medicine

Join to view full profile

Dr. Wilck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wilck's full profile

Already have an account?

Office
3400 Spruce St.
3 Silverstein Bldg., Suite D
Philadelphia, PA 19104
Phone+1 215-662-6932

Fax+1 617-662-7899

Education & Training

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2004 - 2007
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2000 - 2004
Yale-New Haven Medical CenterFellowship, Medical Microbiology, 1999 - 2000
University of Cape Town Faculty of MedicineClass of 1996

Certifications & Licensure

PA State Medical License 2010 - 2024
MA State Medical License 2005 - 2010
DC State Medical License 2003 - 2004
DE State Medical License 2002 - 2003
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

5 citations
Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.
Sebastian Schneeweiss, Peggy L. Carver, Kausik Datta, Alicia Galar, Melissa D. Johnson
The Journal of Antimicrobial Chemotherapy. 2019-10-03
12 citations
Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidru...
J.P. Mills, Marissa B. Wilck, B.C. Weikert, Paige M. Porrett, D. Timko
Transplant Infectious Disease. 2016-10-01
176 citations
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.
Mohamed A. Kharfan-Dabaja, Michael Boeckh, Marissa B. Wilck, Amelia Langston, Alice H Chu
The Lancet. Infectious Diseases. 2012-04-01